Improvement of risk assessment in cutaneous melanoma (CM) by a prognostic 31-gene expression profile (31-GEP) test over AJCC-based staging alone

Improvement of risk assessment in cutaneous melanoma (CM) by a prognostic 31-gene expression profile (31-GEP) test over AJCC-based staging alone

Abstract not available. Disclosures: Study sponsored by Castle Biosciences. Copyright 2018 SKIN

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Skin (Milwood, N.Y.) N.Y.), 2018-12, Vol.2, p.S70
Hauptverfasser: Prado, Giselle, Cook, Robert W, Covington, Kyle R, Monzon, Federico A, Rigel, Darrell S
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract not available. Disclosures: Study sponsored by Castle Biosciences. Copyright 2018 SKIN
ISSN:2574-1624
2574-1624
DOI:10.25251/skin.2.supp.70